Verdict Express — 2 Minutes
B+
Overall Score
Conviction 68%
Aehr Test Systems is the undisputed leader in wafer-level test and burn-in for SiC/GaN power semiconductors. The company has expanded into AI data center processor testing with a $14M contract win, triggering a William Blair upgrade to Outperform with a $50-$70 fair value range. After a +100% YTD rally, the stock just pulled back -12% on profit-taking, creating a potential re-entry. Revenue is in a transition year (-26.5% growth) as the SiC market digests EV overcapacity, but the AI TAM expansion ($1.5B-$2.3B by 2030) is the game-changer.
Strengths
- Only pure-play wafer-level burn-in — irreplaceable in SiC/GaN testing
- AI data center expansion — $14M contract for photonics/processor testing
- William Blair upgrade — $50-$70 fair value, 30% market share projection
- $30.8M cash, $10.2M debt — solid balance sheet, no dilution risk
- +100% YTD momentum with institutional accumulation (70.7%)
Risks
- Revenue declining -26.5% — SiC transition year, EV market slowdown
- Negative EBITDA (-$8.9M) — operating margins at -49.2%
- Beta 2.31 — extremely volatile, 2x market swings
- 17.45% short interest — bears see overvaluation at 20x EV/Revenue
Company Overview
Aehr Test in one sentence: Aehr designs and manufactures semiconductor test and burn-in systems that verify chip reliability at the wafer level — before they are cut and packaged — critical for SiC power semiconductors in EVs, AI data center processors, and photonics devices.
1977
Founded (Fremont, CA)
Product Portfolio
| Product | Function | Key Markets | Status |
| FOX-XP |
Full wafer test & burn-in (up to 300mm) |
SiC power, AI processors, photonics |
Flagship |
| FOX-NP |
Singulated die/module burn-in |
Memory, MCU, SoC, sensors |
Production |
| FOX-CP |
Low-cost single-wafer compact test |
Logic, memory, photonics |
Production |
| FOX WaferPak |
Full wafer contactor (up to 300mm) |
All FOX platforms |
Consumable |
| DiePak |
Singulated die carrier for burn-in |
All applications |
Consumable |
Why wafer-level test matters: In high-power applications like EV inverters and AI data center processors, a single defective chip can cause catastrophic system failures. Testing at the wafer level (before cutting) catches defects earlier and cheaper than package-level testing. For SiC devices that operate at extreme temperatures and voltages, burn-in (stress testing) is mandatory — and Aehr's FOX platform is the only commercial system that does this at full wafer scale. This creates a significant competitive moat.
Revenue Diversification — The AI Pivot
News & Catalysts
AI CONTRACT WIN:
Aehr secured a
$14M order for wafer-level test and burn-in systems tied to AI data center processors and photonics applications — marking its entry into the massive AI semiconductor testing market.
Simply Wall St· mar 8, 2026
William Blair upgraded AEHR from Market Perform to Outperform, estimating fair value at $50-$70 per share. The firm cited multiple design wins for both package-level and wafer-level burn-in across at least two major customers, with a proprietary model forecasting a $1.5B-$2.3B TAM for AI processor burn-in tools by 2030. At 30% market share, Blair projects $50-$70 fair value.
Insider Monkey· mar 6, 2026
AEHR surged 46% in February while the S&P 500 fell 0.9% and Nasdaq declined 3.4%. The rally was driven by new contract wins and growing excitement about the AI data center testing opportunity. Stock is now +100% YTD.
Motley Fool· mar 6, 2026
After running from $22 to $41 in 8 weeks, profit-taking hit AEHR hard with a -12% single-day decline to $35.97. Classic sell-the-news after the analyst upgrade. This pullback brings the price back to the 20-day EMA ($35.56), which historically acts as dynamic support in uptrends.
Massive gap up from $26.83 to $31.81 on contract announcement news. This gap remains unfilled and creates a natural support zone. Gaps of this size on high volume typically signal institutional accumulation.
Fundamentals
$30.8M
Total Cash
Healthy balance
$10.2M
Total Debt
Low leverage
$53.2M
TTM Revenue
-26.5% YoY
-$8.9M
EBITDA
Transition year
Financial Summary
| Metric | Value | Interpretation |
| Market Cap |
$1.10B |
Mid-cap semi equipment |
| Revenue Growth (YoY) |
-26.5% |
SiC order digestion cycle |
| Gross Margins |
33.3% |
Equipment maker typical |
| Operating Margins |
-49.2% |
Heavy R&D investment for AI pivot |
| Net Margins |
-16.6% |
Losses narrowing vs operating |
| Price/Book |
8.34x |
Reflects growth premium |
| EV/Revenue |
20.1x |
Premium valuation for declining revenue |
| Book Value/Share |
$4.27 |
Tangible asset base |
| Analyst Target |
$36.33 |
Consensus near current price |
| Recommendation |
Buy |
Consensus bullish |
Quarterly Earnings Track Record
| Quarter | EPS Actual | EPS Estimate | Surprise |
| Q1 2025 | $0.07 | $0.04 | +75% beat |
| Q2 2025 | -$0.01 | -$0.015 | Beat |
| Q3 2025 | $0.01 | $0.00 | Beat |
| Q4 2025 | -$0.04 | -$0.037 | Miss |
Annual Revenue & Earnings Trajectory
The revenue dip is cyclical, not structural: Aehr's revenue peaked at $66.2M (FY2023) when SiC adoption for EVs was booming. The current -26.5% decline reflects the EV industry's inventory digestion cycle — not a loss of competitive position. The company is using this transition period to invest heavily in AI data center testing capabilities, which represent a TAM 10x larger than SiC alone. As new AI contracts ramp (like the $14M order), revenue is expected to reaccelerate in FY2026-2027.
Insiders & Institutions
70.7%
Institutional Ownership
Strong institutional interest
5.35%
Insider Ownership
Management skin in the game
30.6M
Shares Outstanding
No recent dilution
27.2M
Float
88.9% of outstanding
Insider alignment is positive: With 5.35% insider ownership and 70.7% institutional ownership, AEHR's shareholder base is dominated by long-term holders. No significant insider selling has been reported despite the +100% YTD rally — a strong signal of management confidence in the company's growth trajectory. The $30.6M shares outstanding have been stable, indicating no dilutive offerings.
Capital Structure & Dilution Risk
Clean capital structure: Unlike many small-cap tech companies, AEHR has a remarkably clean capital structure. With $30.8M in cash against only $10.2M in total debt, the company has positive net cash of $20.6M. No toxic PIPE deals, no convertible notes, no ATM programs. The shares outstanding have been stable at ~30.6M, showing management discipline. The primary risk is that if the AI transition takes longer than expected, the company may need to raise capital — but the current cash position provides approximately 3+ years of runway at the current burn rate.
Short Interest & Squeeze Potential
Short interest is elevated but CTB has collapsed: At 17.45% of float short, bears maintain a significant position. However, the cost to borrow has plummeted from 12-15% a year ago to just 0.45% today, and share availability has expanded to 750,000. This suggests shorts are no longer under squeeze pressure and may be positioning for a fundamental thesis (overvaluation at 20x EV/Revenue). The 3.6 days to cover is moderate — enough for a short squeeze if a catalyst forces covering, but not at critical levels. No FTD threshold issues detected.
Options & Derivatives
| Metric | Value | Signal |
| Options Volume (Daily) | 2,198 | Normal activity |
| Call Volume | 1,779 | Bullish bias |
| Put Volume | 419 | Light hedging |
| Put/Call Volume Ratio | 0.24 | Very bullish skew |
| Max Pain Strike | $22.50 | Far below current ($35.97) |
| Unusual Activity | None | No sweeps detected |
Options signal bullish positioning: The 2.92 call/put OI ratio is strongly bullish, with nearly 3x more call open interest than puts. The daily put/call volume ratio of 0.24 confirms active call buying. However, the max pain at $22.50 is significantly below the current price of $35.97 — this divergence suggests that if options market makers are hedged, there could be downward pressure into expiration (March 20). No unusual options activity detected, which means this is organic positioning rather than informed trading ahead of a catalyst.
Technical Analysis (Daily)
52.5
RSI (14)
Neutral zone
3.55
MACD
Above signal (3.35)
$4.86
ATR (14)
High volatility
Markup
Wyckoff Phase
Bullish structure
Moving Averages
| Indicator | Value | Price vs. | Signal |
| EMA 20 | $35.56 | +1.2% above | Immediate support |
| EMA 50 | $30.89 | +16.4% above | Strong uptrend |
| EMA 200 | $23.86 | +50.8% above | Major bull trend |
| VWAP | $17.76 | +102% above | Above all anchored VWAPs |
Support & Resistance Levels
| Level | Price | Strength | Basis |
| Resistance 1 | $44.25 | 70/100 | Historical resistance, 2 touches |
| Support 1 | $30.89 | 85/100 | EMA 50 — dynamic support |
| Support 2 | $26.83 | 80/100 | Gap fill from Feb 11 breakout |
| Support 3 | $22.64 | 80/100 | Strong multi-touch level, 3 touches |
| Support 4 | $22.06 | 80/100 | Major multi-year support |
Technical structure remains bullish: AEHR is trading above all major moving averages (EMA 20/50/200) and the Wyckoff phase is "Markup" with buying imbalance. The RSI at 52.5 is neutral after the pullback, providing room for another leg up. The MACD remains positive and above its signal line. The key level to watch is EMA 20 at $35.56 — a close below this on volume would signal a deeper correction toward EMA 50 at $30.89. The OBV trend is neutral, suggesting the current pullback is healthy profit-taking rather than distribution.
Sector & Peer Comparison
Correlation Analysis
| Peer | Correlation | Sector |
| COHU | 0.45 | Semi Equipment — Test |
| GFS (GlobalFoundries) | 0.44 | Semiconductor Foundry |
| ACLS (Axcelis) | 0.44 | Semi Equipment — Ion Implant |
| ON Semi | 0.43 | SiC Power Semiconductors |
| KLAC (KLA Corp) | 0.42 | Semi Equipment — Inspection |
| LRCX (Lam Research) | 0.42 | Semi Equipment — Etch |
Index Correlations
| Index/ETF | Correlation | Interpretation |
| IWM (Russell 2000) | 0.43 | Strong small-cap correlation |
| SPY (S&P 500) | 0.06 | Nearly uncorrelated |
| QQQ (Nasdaq 100) | -0.01 | Zero correlation |
| GLD (Gold) | 0.09 | No relationship |
| TLT (Bonds) | -0.003 | No relationship |
AEHR trades on its own story, not the macro: With near-zero correlation to SPY, QQQ, and bonds, AEHR is a stock-picker's stock. Its highest correlation is with IWM (0.43), consistent with its small-cap profile. The correlation with ON Semi (0.43) makes sense — ON is a major SiC customer. The near-zero correlation to Nasdaq means AEHR can outperform even in tech selloffs (as proven in February 2026: +46% while Nasdaq was -3.4%).
Macro Environment
| Factor | Current | Impact on AEHR |
| EV Market Growth | Slowing short-term | SiC order digestion underway |
| AI Data Center CapEx | $200B+ annually | Massive new TAM for testing |
| SiC Market (2030 TAM) | $15B+ | Long-term structural driver |
| US CHIPS Act | Active subsidies | Benefits domestic semi equipment |
| Fed Rate Path | Holding | Growth stocks sensitive to rates |
| China/EV Tariffs | Escalating | AEHR sells to US/Asia/EU customers |
The AI data center opportunity is the key macro catalyst: While EV-driven SiC demand is temporarily soft, the explosion in AI data center buildout is creating a new, potentially larger market for Aehr. AI processors (GPUs, TPUs, custom ASICs) require extensive burn-in testing for reliability at scale. William Blair estimates the AI burn-in tool TAM at $1.5B-$2.3B by 2030 — compared to AEHR's current $53M revenue. If AEHR captures even 10% of this market, it represents a 3-4x revenue increase. The US CHIPS Act provides additional tailwinds for domestic semiconductor equipment makers.
Social Radar — Multi-Platform Analysis
StockTwits
30 msgs / 48h
Positive
11,702 watchers • Bullish sentiment
Reddit / WSB
Moderate mentions
Growing
Semi equipment niche • Not a meme stock
X / Twitter
$AEHR trending
Active
FinTwit coverage increasing post-upgrade
Google Trends
Search spike
+200% vs avg
Correlates with price rally
YouTube
~10 recent videos
Normal
Mostly semi equipment analysis, no pump
Analysts
3 covering
Buy
Target: $36.33 avg • William Blair: $50-$70
Recent StockTwits Messages
@pp_pp Mar 8 · Positive
"AEHR has NEW solution (tests) which were NOT available in the market some time ago. Wafer level tests, even BEFORE laser cutting. When you are testing AI or EV or memory chips [...] best solution is to test chips BEFORE they are soldered or packed."
@stockdawg999 Mar 7 · Positive
"Can see this going $80-$100"
Pump & Dump Score: 0/6
No abnormal mention spike without news
No new accounts dominating posts
No specific price promises
Rally driven by contract wins, not hype
Float 27M — not micro-float manipulation target
3 analysts covering, William Blair upgrade
Clean — Legitimate Institutional Activity
Risk Analysis
Risk Profile: Elevated
AEHR carries elevated risk due to revenue cyclicality, high valuation multiples during a transition year, extreme beta (2.31), and significant short interest. However, strong balance sheet and expanding TAM partially offset these concerns.
Revenue Cyclicality
High Beta
Valuation Premium
Balance Sheet
Short Pressure
- Revenue declined -26.5% YoY as SiC market digests EV overcapacity
- Lumpy order pattern — single large customers can move revenue significantly
- AI pivot is promising but unproven at scale
Revenue recovery timeline is uncertain; AI ramp could take 12-18 months
- EV/Revenue at 20.1x on declining revenue is aggressive
- Price/Book at 8.34x vs semi equipment peers at 3-5x
- Stock has doubled YTD — much good news already priced in
Valuation justified only if AI TAM materializes; vulnerable to multiple compression
- Beta of 2.31 means 2x market swings in both directions
- ATR of $4.86 = ~13.5% daily range at current price
- Has moved ±15% in a single day multiple times in 2025-2026
Position sizing must account for 2x market volatility; tight stops will get triggered
- 17.45% of float short — bears see the valuation gap
- CTB collapsed from 12-15% to 0.45% — shorts comfortable
- 3.6 days to cover provides potential squeeze fuel
Shorts are comfortable but 17% SI creates potential for violent squeezes on good news
- SiC business concentrated with 2-3 major customers (ON Semi, STMicro, Wolfspeed)
- Loss of any single customer would materially impact revenue
- AI contract wins diversify but are still early-stage
Customer diversification improving with AI entry but SiC remains concentrated
- $30.8M cash, $10.2M debt = $20.6M net cash
- No warrants, no convertibles, no ATM programs
- 3+ years runway at current burn rate
Clean balance sheet with no dilution risk in the near term
Why AEHR is priced where it is: The stock trades at a premium EV/Revenue (20x) because the market is pricing in the AI data center TAM expansion. The -12% pullback reflects healthy profit-taking after a +100% YTD run. The bear case is simple: revenue is declining, margins are negative, and the AI opportunity is still unproven. The bull case: Aehr is the only pure-play in an emerging $1.5B-$2.3B market with proven technology and real contract wins. The truth likely falls somewhere in between, which is why we rate it B+ rather than A.
SEC Filings & Institutional Watch
| Date | Filing | Description | Signal |
| Jan 12, 2026 |
10-Q |
Quarterly financial report |
Standard filing |
| Jan 8, 2026 |
8-K (2.02, 9.01) |
Results of operations & financial statements |
Earnings release |
| Nov 7, 2025 |
8-K (5.02, 9.01) |
Departure/election of directors or officers |
Management change |
| Oct 21, 2025 |
8-K (5.07) |
Submission of matters to vote of security holders |
Routine governance |
| Oct 8, 2025 |
10-Q |
Quarterly financial report |
Standard filing |
Hostile Fund Verdict
No hostile funds detected. No Schedule 13D filings (activist investors), no short seller reports from Hindenburg/Citron/Muddy Waters. No FTD threshold issues, not on the most shorted list. The SEC filing history is clean with standard quarterly reports and a routine management change. This is a company with legitimate institutional ownership and no signs of predatory fund activity.
Seasonality & Patterns
Best months historically: July (+2.64% avg) and September (+0.64%) are AEHR's strongest months, while March (-0.62%) and April (-0.35%) tend to be weaker. The current March timing is seasonally unfavorable, which may contribute to the pullback. However, with such a strong fundamental catalyst (AI contracts), seasonality may be overridden. Monday is historically the best day of the week (+0.98% avg return), while Thursday is flat (+0.01%).
Trade Idea
Entry Zone
$33.00 - $36.00
EMA 20 support ($35.56) & pullback zone
Stop Loss
$29.50
Below EMA 50 ($30.89) — -18% max loss
Target 1
$44.25
Historical resistance — +23% upside
Target 2
$55.00
William Blair low-end target — +53% upside
R/R = 1:1.9 (TP1) — 1:3.5 (TP2)
Trade Thesis
AEHR is pulling back -12% after a massive rally, bringing the price back to the 20-day EMA. The fundamental story is stronger than ever: AI data center testing is a new $1.5B-$2.3B TAM, William Blair upgraded with $50-$70 fair value, and real $14M contracts are being signed. This is a pullback-to-support entry on a stock with institutional backing, not a reversal. The risk is that the SiC transition takes longer and the AI contracts don't ramp fast enough to offset the revenue decline.
Confirmation Signals
- Hold above EMA 20 ($35.56) on daily close — confirms uptrend intact
- New AI contract announcement — validates the TAM expansion thesis
- Volume spike on bounce from support — institutional accumulation
- RSI holding above 45 on the pullback — bullish momentum maintained
Invalidation Signals
- Close below EMA 50 ($30.89) on volume — trend break confirmed
- Customer loss announcement — SiC revenue at risk
- Earnings miss with lowered guidance — AI pivot not offsetting SiC decline
- Secondary offering — dilution would undermine the thesis
Timing & Sizing
Horizon: Swing to medium-term (4-12 weeks). Catalyst: Next earnings report & potential new AI contracts. Sizing: 2-3% of portfolio max given Beta 2.31 and high volatility. Entry strategy: Scale in 1/3 at $35-36, 1/3 at $33, 1/3 at $31 (EMA 50). This gives an average entry of ~$33 with a cleaner R/R. Use wide stops given ATR of $4.86.
Overall Rating
B+
Conviction: 68%
Bias: Bullish
| Profile | Growth / Momentum |
| Bias | Bullish (AI TAM expansion + pullback entry) |
| Confidence | 68% — limited by revenue transition uncertainty |
| Time Horizon | Medium-term (3-12 months) |
| Suitable For | Growth-oriented investors comfortable with volatility |
Key Takeaways
Bull Case
- Only pure-play in AI burn-in testing with proven technology
- $1.5B-$2.3B AI TAM by 2030 vs $53M current revenue
- William Blair $50-$70 fair value with institutional upgrade
Bear Case
- Revenue declining -26.5% with negative EBITDA
- 20x EV/Revenue is stretched for a cyclical equipment maker
- 17.45% short interest reflects real valuation concerns
Mindset Tip
AEHR is a high-conviction, high-volatility name. After +100% YTD, it is natural to feel FOMO on any pullback. But remember: the best entries come when the stock pulls back to support, not when it is making new highs. Scale in gradually, use position sizing that accounts for a Beta of 2.31, and have a clear plan for both winning and losing scenarios. If the AI thesis is right, patience will be rewarded. If it is wrong, your stop loss protects you.
Sources & Disclaimer
Disclaimer:
This analysis is for educational and informational purposes only. It is not financial advice, and does not constitute a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions. Market Watch and its contributors hold no positions in AEHR at the time of publication.
Social Radar — Multi-Platform Analysis
Recent StockTwits Messages
"AEHR has NEW solution (tests) which were NOT available in the market some time ago. Wafer level tests, even BEFORE laser cutting. When you are testing AI or EV or memory chips [...] best solution is to test chips BEFORE they are soldered or packed."
"Can see this going $80-$100"
Pump & Dump Score: 0/6